High on-treatment platelet reactivity as a risk factor for secondary prevention after coronary stent revascularization: A landmark analysis of the ARCTIC study.

MLA

Montalescot, Gilles, et al. “High On-Treatment Platelet Reactivity as a Risk Factor for Secondary Prevention after Coronary Stent Revascularization: A Landmark Analysis of the ARCTIC Study.” Circulation, vol. 129, no. 21, May 2014, pp. 2136–43. EBSCOhost, https://doi.org/10.1161/CIRCULATIONAHA.113.007524.

APA

Montalescot, G., Rangé, G., Silvain, J., Bonnet, J.-L., Boueri, Z., Barthélémy, O., Cayla, G., Belle, L., Van Belle, E., Cuisset, T., Elhadad, S., Pouillot, C., Henry, P., Motreff, P., Carrié, D., Rousseau, H., Aubry, P., Monségu, J., Sabouret, P., … Collet, J.-P. (2014). High on-treatment platelet reactivity as a risk factor for secondary prevention after coronary stent revascularization: A landmark analysis of the ARCTIC study. Circulation, 129(21), 2136–2143. https://doi.org/10.1161/CIRCULATIONAHA.113.007524

Chicago

Montalescot, Gilles, Grégoire Rangé, Johanne Silvain, Jean-Louis Bonnet, Ziad Boueri, Olivier Barthélémy, Guillaume Cayla, et al. 2014. “High On-Treatment Platelet Reactivity as a Risk Factor for Secondary Prevention after Coronary Stent Revascularization: A Landmark Analysis of the ARCTIC Study.” Circulation 129 (21): 2136–43. doi:10.1161/CIRCULATIONAHA.113.007524.